Silk Road Therapies, Inc. is a biopharmaceutical company dedicated to the development and commercialization of medicines for patients with rare (orphan) diseases.

Silk Road Therapies’ unique business model is to repropose well-understood active ingredients in existing, approved drug products, and to develop them into treatments for specific rare disease. This approach enables us to be able to develop and commercialize products much faster and cost effective.

Our business model pairs a core management team of rare disease experts with an extensive network of academic researchers, specialized consultants, third party service providers and contractors. We have expertise in clinical development, regulatory affairs, and commercialization of rare disease medicines.